Irritable Bowel Syndrome (IBS) Treatment Market to Grow at a CAGR of 10.1% to reach US$ 4,600.30 Million from 2021 to 2028

The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028.

The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth.

Download Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006814/?utm_source=OpenPR&utm_medium=10379

Key Players Analysis:                                   
Ironwood Pharmaceuticals, Inc.
AbbVie.
Sebela Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Alfasigma S.p.A.
Astellas Pharma Inc.
AstraZeneca
Synthetic Biologics, Inc.
Bausch + Lomb Incorporated
Lannett Company Inc
 
The report covers key developments in the Irritable Bowel Syndrome (IBS) Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Irritable Bowel Syndrome (IBS) Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Irritable Bowel Syndrome (IBS) Treatment in the global market. Below mentioned is the list of few companies engaged in the Irritable Bowel Syndrome (IBS) Treatment market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.

Market Insights
Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
Irritable bowel syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping. Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. A data published by International Foundation for Gastrointestinal Disorders states that among all IBS patients, about 40% patients have mild IBS, around 35% have moderate IBS, and an estimated 25% suffer from severe IBS. Many people don't recognize IBS symptoms.

Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that can cause IBS. These factors are projected to accelerate the rate of IBS prevalence across the world. For instance, according to a study published on NCBI in 2018, IBS is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of IBS is likely to boost the irritable bowel syndrome (IBS) treatment market during the forecast period.

 The COVID-19 outbreak is currently going the world over, the Irritable Bowel Syndrome (IBS) Treatments Market report covers the impact of the corona-virus on top company’s growth. This research report categorizes as the key players in the Irritable Bowel Syndrome (IBS) Treatments market and also gives a comprehensive study of Covid-19 impact analysis of the market by regions like (Americas, Europe APAC, and EMEA).

ASSESING THE COVID-19 IMPACT on Irritable Bowel Syndrome (IBS) Treatment Market? Visit Here for PDF Copy >> https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00006814/?utm_source=OpenPR&utm_medium=10379

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Irritable Bowel Syndrome (IBS) Treatment Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Irritable Bowel Syndrome (IBS) Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report offers key drivers that propel the growth in the global Irritable Bowel Syndrome (IBS) Treatment market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Irritable Bowel Syndrome (IBS) Treatment Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Irritable Bowel Syndrome (IBS) Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.          

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00006814/?utm_source=OpenPR&utm_medium=10379

Contact US
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.